Template:Primary hyperaldosteronism: Difference between revisions

Jump to navigation Jump to search
m (Usama Talib moved page Template:Conn syndrome to Template:Primary hyperaldosteronism without leaving a redirect)
No edit summary
 
(7 intermediate revisions by 3 users not shown)
Line 3: Line 3:
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |


'''Conn syndrome Microchapters
'''Primary hyperaldosteronism Microchapters
'''
'''
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
Line 10: Line 10:
|- bgcolor="LightCoral"
|- bgcolor="LightCoral"
!
!
[[Conn syndrome|Home]]
[[Primary hyperaldosteronism|Home]]
|-  
|-  
!
!
Line 16: Line 16:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Conn syndrome overview|Overview]]
[[Primary hyperaldosteronism Patient Information|Patient Information]]
|-  
|-  
!
!
Line 22: Line 22:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Conn syndrome historical perspective|Historical Perspective]]
[[Primary hyperaldosteronism overview|Overview]]
|-  
|-  
!
!
Line 28: Line 28:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Conn syndrome pathophysiology|Pathophysiology]]
[[Primary hyperaldosteronism historical perspective|Historical Perspective]]
|-  
|-  
!
!
Line 34: Line 34:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Conn syndrome causes|Causes]]
[[Primary hyperaldosteronism classification|Classification]]
|-  
|-  
!
!
Line 40: Line 40:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Conn syndrome differential diagnosis|Differentiating Conn syndrome from other Diseases]]
[[Primary hyperaldosteronism pathophysiology|Pathophysiology]]
|-  
|-  
!
!
Line 46: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Conn syndrome epidemiology and demographics|Epidemiology and Demographics]]
[[Primary hyperaldosteronism causes|Causes]]
|-  
|-  
!
!
Line 52: Line 52:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Conn syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]]
[[Primary hyperaldosteronism differential diagnosis|Differentiating Primary Hyperaldosteronism from other Diseases]]
|-
!
 
|- bgcolor="Pink"
!
[[Primary hyperaldosteronism epidemiology and demographics|Epidemiology and Demographics]]
|-
!
 
|- bgcolor="Pink"
!
[[Primary hyperaldosteronism Risk Factors|Risk Factors]]
|-
!
 
|- bgcolor="Pink"
!
[[Primary hyperaldosteronism Screening|Screening]]
|-
!
 
|- bgcolor="Pink"
!
[[Primary hyperaldosteronism natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 64: Line 88:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Conn syndrome history and symptoms|History and Symptoms]]
[[Primary hyperaldosteronism Diagnostic study of choice|Diagnostic study of choice]]
|-  
|-  
!
!
Line 70: Line 94:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Conn syndrome physical examination|Physical Examination]]
[[Primary hyperaldosteronism history and symptoms|History and Symptoms]]
|-  
|-  
!
!
Line 76: Line 100:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Conn syndrome laboratory findings|Laboratory Findings]]
[[Primary hyperaldosteronism physical examination|Physical Examination]]
|-  
|-  
!
!
Line 82: Line 106:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Conn syndrome other imaging findings|Other Imaging Findings]]
[[Primary hyperaldosteronism laboratory findings|Laboratory Findings]]
|-  
|-  
!
!
Line 88: Line 112:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Conn syndrome other diagnostic studies|Other Diagnostic Studies]]
[[Primary hyperaldosteronism CT scan Findings|CT scan Findings]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Primary hyperaldosteronism MRI Findings|MRI Findings]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Primary hyperaldosteronism other imaging findings|Other Imaging Findings]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Primary hyperaldosteronism other diagnostic studies|Other Diagnostic Studies]]
|-  
|-  
!
!
Line 100: Line 142:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Conn syndrome medical therapy|Medical Therapy]]
[[Primary hyperaldosteronism medical therapy|Medical Therapy]]
|-
!
 
|- bgcolor="PaleTurquoise"
!
[[Primary hyperaldosteronism surgery|Surgery]]
|-
!
 
|- bgcolor="PaleTurquoise"
!
[[Primary hyperaldosteronism Primary Prevention|Primary Prevention]]
|-  
|-  
!
!
Line 106: Line 160:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Conn syndrome surgery|Surgery]]
[[Primary hyperaldosteronism Secondary Prevention|Secondary Prevention]]
|-  
|-  
!
!
Line 112: Line 166:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Conn syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[Primary hyperaldosteronism cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!  
Line 124: Line 178:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Conn syndrome case study one|Case #1]]
[[Primary hyperaldosteronism case study one|Case #1]]
|-  
|-  
!
!

Latest revision as of 16:37, 6 November 2017